Quvium ’s cough monitor boosts compliance by involving caregivers

When Steven Schmidt worked at Vertex Pharmaceuticals (NSDQ:VRTX), Eric Olson – the man who led the development of the 1st drug to treat the underlying causes of cystic fibrosis – asked Schmidt to look into ways that families could become more engaged with managing a patient’s condition. Olson pointed towards a publication that showed that involving caregivers added 8 years of life expectancy to children with cystic fibrosis. Schmidt, who now serves as founder and CEO of Quvium, took that idea and began development of a wearable cough monitor that alerts patients’ caregivers when a cough is out of the ordinary. At the Medical Sensors Design Conference earlier this month, Schmidt explained that 10 million children ages 0 to 4 went to the emergency room last year for excessive cough and 2 million children ages 0 to 4 use a nebulizer. This large patient population could use a solution that would help prevent unnecessary trips to urgent care and give their families ease of mind, Schmidt said. Get the full story at our sister site, Drug Delivery Business News. The post Quvium’s cough monitor boosts compliance by involving caregivers appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Drug-Device Combinations Patient Monitoring Pharmaceuticals Respiratory Wall Street Beat quvium Source Type: news